FindTrial
Sign In

An assessment of nutritional deficiencies in patients with primary antibody deficiency and bronchiectasis.

An assessment of nutritional deficiencies in patients with primary antibody deficiency and bronchiectasis. - BE-PAD nutrition study (pilot)

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46112
Enrollment
25
Registered
2018-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchiectasieen defects of immune system immune deficiency

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosis of primary antibody deficiency - Bronchiectasis diagnosed by chest CT scanning - Informed consent

Exclusion criteria

Exclusion criteria: - Inability to give informed consent - Active infection/ exacerbation requiring antibiotic treatment in the 2 weeks prior to study inclusion

Design outcomes

Primary

MeasureTime frame
7.1.1 Main study parameter/endpoint - Dietary intake of micro- and micronutrients - Body composition as estimated with bioelectrical impedance analysis - Serum levels of micro- and macro nutrients—

Secondary

MeasureTime frame
7.1.2 Secondary study parameters/endpoints - demographic information, - height, weight, - type of PAD, - extent of bronchiectasis as measured by BRICS score, - lung function (FEV1/ FVC) - exacerbation frequency in year prior to study inclusion - markers of systemic inflammation (CRP/ WBC count) - sputum microbiology - Bronchiectasis severity scores (BSI and FACED scores) - QoL and symptoms as measured by LRTI-VAS, CVID-QoL and QOL-B—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)